FORA Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
3,067
-2,380
| -44% | -$1.25M | 0.18% | 150 |
|
|
2025
Q1 | $3.45M | Buy |
5,447
+2,894
| +113% | +$1.84M | 0.35% | 89 |
|
|
2024
Q4 | $1.82M | Buy |
2,553
+1,369
| +116% | +$975K | 0.21% | 145 |
|
|
2024
Q3 | $1.24M | Sell |
1,184
-4,229
| -78% | -$4.45M | 0.15% | 185 |
|
|
2024
Q2 | $5.69M | Sell |
5,413
-1,911
| -26% | -$2.01M | 0.69% | 35 |
|
|
2024
Q1 | $7.05M | Buy |
+7,324
| New | +$7.05M | 0.58% | 48 |
|
|
2023
Q4 | – | Sell |
-8,244
| Closed | -$6.78M | – | 607 |
|
|
2023
Q3 | $6.78M | Buy |
+8,244
| New | +$6.78M | 0.6% | 44 |
|
|
2023
Q2 | – | Sell |
-9,504
| Closed | -$7.81M | – | 577 |
|
|
2023
Q1 | $7.81M | Buy |
+9,504
| New | +$7.81M | 0.78% | 29 |
|
|
2022
Q4 | – | Sell |
-7,204
| Closed | -$4.96M | – | 631 |
|
|
2022
Q3 | $4.96M | Buy |
+7,204
| New | +$4.96M | 0.95% | 18 |
|
|
2022
Q2 | – | Sell |
-5,250
| Closed | -$3.64M | – | 646 |
|
|
2022
Q1 | $3.64M | Buy |
+5,250
| New | +$3.64M | 0.66% | 29 |
|
|
2021
Q4 | – | Sell |
-5,006
| Closed | -$3.03M | – | 435 |
|
|
2021
Q3 | $3.03M | Buy |
5,006
+1,306
| +35% | +$790K | 0.76% | 32 |
|
|
2021
Q2 | $2.07M | Buy |
+3,700
| New | +$2.07M | 0.38% | 63 |
|
|
2021
Q1 | – | Sell |
-281
| Closed | -$136K | – | 1040 |
|
|
2020
Q4 | $136K | Buy |
+281
| New | +$136K | 0.02% | 589 |
|
|
2020
Q1 | – | Sell |
-5,278
| Closed | -$1.98M | – | 1282 |
|
|
2019
Q4 | $1.98M | Buy |
+5,278
| New | +$1.98M | 0.2% | 132 |
|